Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Apply
Donanemab & Usual Care
A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step